Biology subjects

Xiao, Z.

Publications and source records attributed to Xiao, Z..

At least 37 records · Page 2Linked to original sources

bioRxiv2025

Evo2HiC: a multimodal foundation model for integrative analysis of genome sequence and architecture

Understanding how genomic sequences shape three-dimensional (3D) genome architecture is funda-mental to interpreting diverse biological processes. Although previous studies have shown that sequence information can predict 3D genome architecture, they fall short in capturing cell type-specific structures because they are trained solely on sequence inputs. The widely available Hi-C data, which contain rich structural information across biosamples, can provide complementary features to sequence data for study-ing cell type-specific architectures. Recently, DNA foundation models have demonstrated encouraging performance in capturing long-range genomic dependencies, holding promise for modeling chromatin interactions. However, the extremely high computational cost of running these models limits their applicability to Hi-C analysis, which requires genome-wide sequence embeddings. Here, we present Evo2HiC, a multimodal foundation model that jointly models genomic sequences and structures to study cell type-specific chromatin structure. The key idea of Evo2HiC is to distill a large-scale DNA foundation model, Evo 2 (7B), into a compact encoder, while guiding the distillation with Hi-C data to preserve genomic features critical for 3D genome analysis. The model supports two types of encoders, one that operates directly on DNA sequences, and a second that additionally takes as input corresponding Hi-C data. Using the DNA-only encoder and predicting Hi-C contact matrices, Evo2HiC improved Spearman correlation by 10.9% over Orca. Moreover, by jointly embedding Hi-C and sequence information Evo2HiC achieved the best overall Pearson correlation when predicting five representative epigenomic assays. Interpretation analysis of Evo2HiC revealed its ability to identify cell type-specific sequence motifs that explain changes in epigenomic signals. Finally, we demonstrated the cross-species generalizability of Evo2HiC on 177 species from the DNA Zoo dataset for Hi-C resolution enhancement. In summary, Evo2HiC is a foundation model that integrates genome sequences and 3D chromatin structure information, substantially reduces computational cost while maintaining state-of-the-art accuracy on predicting various epigenomic signals and genome architecture, enables the identification of cell type-specific motifs, and demonstrates robust generalizability across species.

bioinformatics↗

bioRxiv2025

Human-mouse cross-species comparison identifies common and unique aspects of intestinal mesenchyme development

Using single-cell RNA sequencing (scRNA-seq) and histological approaches, we examine cross-species cellular identity, diversity and organization of mesenchymal (fibroblast) populations in the developing mouse and human intestines. In both species, we defined 7 fibroblast populations. Using cross-species integration and label transfer approaches we find that each mesenchymal cell subtype in the murine intestine is highly concordant to a cell type/state in the human intestine, and vice-versa, suggesting a strong conservation of mesenchymal cell types/states across species. Despite this conservation, we also observe that individual lineage-defining genes are not always shared and can be found in different mesenchymal populations. High resolution spatial analysis via fluorescent in situ hybridization (FISH) and immunofluorescence (IF) confirmed these findings and revealed that transcriptionally-defined sub-types of intestinal mesenchymal cells in mice and humans are organized within similar spatial domains.

developmental biology↗

bioRxiv2025

The 2'-endo conformation of arabinose-CTP and arabinose-UTP inhibit viral polymerases by inducing long pauses.

Key to supporting human health in the face of evolving viruses is the development of novel antiviral drug scaffolds with the potential for broad inhibition of viral families. Nucleoside analogs are a key class of drugs that have demonstrated potential for the inhibition of several viral species. Here, we evaluate arabinose nucleotides (ara-NTP) as inhibitors of the SARS-CoV-2 and poliovirus polymerases using biochemistry, biophysics and structural biology. Ara-NTPs compete poorly with their natural counterparts for incorporation into RNA by viral polymerases. However, upon incorporation, ara-NMPs induce long polymerase pausing in both SARS-CoV-2 and poliovirus polymerase RNA elongation. Our studies suggest that subsequent nucleotide incorporation is inhibited at the catalytic step due to the 2-endo sugar pucker of the incorporated ara-NMP.

biochemistry↗

bioRxiv2025

Human hippocampal ripples prioritise model-based learning

Humans often learn optimally, inferring the value of options they have never directly experienced by leveraging internal models of the world, a process known as model-based learning. Yet how the brain decides which unexperienced options to update first remains unclear. Here we recorded intracranial EEG from 34 epilepsy patients performing a reinforcement-learning task that required using task structure to infer the value of unvisited (non-local) paths. After each reward, brief hippocampal "ripple" events signalled which indirect experience was most valuable, thereby encoding that paths priority. Longer ripples carried the strongest priority signals, allowing the brain to update high-value, unvisited options first and thereby optimise learning. Ripple events also coincided with selective cortical reactivation of these high-priority paths, consistent with prioritised replay. Crucially, when hippocampal ripples were precisely synchronised with activity in the lateral frontopolar cortex (LFPC), individuals showed greater model-based learning: stronger ripple-LFPC coupling predicted more effective use of task structure and more accurate learning of non-local values. Our findings establish hippocampal ripple-centred prefrontal coordination as a fundamental mechanism that prioritises valuable experiences for model-based learning, explaining how the human brain learns so efficiently.

neuroscience↗

bioRxiv2025

Human hippocampal ripples loosen medial prefrontal constraints to foster creative thinking

Creative thinking often requires breaking away from dominant mental schemas to generate novel and useful ideas. Yet how the human brain relaxes schematic constraints to enable creativity remains unclear. Using human intracranial EEG recordings, we found that moments of creative idea generation were accompanied by increased hippocampal ripple events, a concurrent reduction in ripple-triggered high-frequency activity in the medial prefrontal cortex (mPFC), and greater divergence of ripple-triggered mPFC activity patterns from the typical, schema-like task state. These effects followed a dorsal-ventral gradient within the mPFC and were most pronounced in the ventromedial PFC (vmPFC), a region heavily involved in schematic representation. Together, our findings suggest that hippocampal ripples can transiently disengage medial prefrontal schema constraints, thereby promoting more flexible and creative thinking.

neuroscience↗

bioRxiv2025

Thioredoxin-1 inhibits granulosa cell ferroptosis to rescue ovarian aging through mitophagy-dependent activation of BNIP3L

Ovarian aging is closely associated with a decline in fertility and an increase in reproductive dysfunction. Ovarian granulosa cells (GCs) support oocyte homeostasis and development, yet insight into GC dysfunction during aging is limited. Here, we show that aged GCs of humans and mice have indications of elevated ferroptosis, including increased ferroptosis-related metabolites, lipid peroxidation, and iron accumulation. The ferroptosis inhibitor Ferrostatin-1 reversed ovarian impairment and fertility of aged mice in vivo. We show that the age-related reduction in the expression of TXN (thioredoxin) leads to ferroptosis in human and mouse GCs by blocking BNIP3L-dependent mitophagy. Exogenous activation of TXN could promote mitophagy, thereby clearing excessive ROS and inhibiting ferroptosis. These results suggest that anti-ferroptosis-related treatments may assist in treating aging-related reproductive disorders. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=107 SRC="FIGDIR/small/664497v1_ufig1.gif" ALT="Figure 1"> View larger version (26K): org.highwire.dtl.DTLVardef@1b97e8forg.highwire.dtl.DTLVardef@123f8d0org.highwire.dtl.DTLVardef@a44c61org.highwire.dtl.DTLVardef@92b32e_HPS_FORMAT_FIGEXP M_FIG C_FIG Key pointsO_LIFerroptosis signatures are upregulated in aged GCs from human and mouse ovaries C_LIO_LITXN is deregulated in aged GCs, leading to mitochondrial and ROS metabolic dysfunction C_LIO_LITXN binds to DNA to regulate autophagy and mitophagy genes, including BNIP3L C_LIO_LIInhibition of ferroptosis can ameliorate GC dysfunction C_LI

cell biology↗

bioRxiv2025

Pluripotent stem cell-derived siTNK cells attack tumors via a synthetic CD8-CD28 TCR complex

Tumor-associated antigen-specific T cell receptor (TCR)-engineered T cells offer a promising strategy for cancer therapy. Natural killer (NK) cells exhibit broad anti-tumor activity with low side effects but lack the capacity to recognize intracellular antigens. Here, we found that the human pluripotent stem cell (hPSC)-derived iNK cells, unlike tissue-isolated NK cells, expressed all four CD3 subunits at the transcriptome level. We introduced a synthetic gene-expressing complex (SCOTR), encoding a tumor antigen- specific TCR, CD8 coreceptor, and CD28 costimulatory molecule, into hPSCs to generate SCOTR-hPSCs. The SCOTR-hPSCs gave rise to abundant synthetic TCR complex-expressing iNK (siTNK) cells via an organoid induction method. These siTNK cells showed HLA-dependent, antigen-specific cytotoxicity against tumor cells and significantly suppressed tumor growth in tumor xenograft animal models, while also preserving universal non-specific tumor-killing activity. Collectively, siTNK cells, as hPSC-derived hybrid cells with dual features of adaptive T and inherent NK cells, offer an artificial cell source for human immunotherapies.

immunology↗

bioRxiv2025

Ciliated cells promote high infectious potential of influenza A virus through the efficient intracellular activation of hemagglutinin

Influenza viruses utilize host proteases to activate the viral fusion protein, hemagglutinin (HA), into its fusion-competent form. Although proteolytic activation of HA is essential for virus replication, the cell-type dependence of HA activation within the airway epithelium and the subcellular location(s) in which it occurs are not well-established. To address these questions, we investigated the proteolytic activation of HA in differentiated human airway epithelial cells using contemporary and historical H1N1 and H3N2 strains. We find that activation is efficient across viral strains and subtypes but depends on cellular tropism, with ciliated cells activating HA more effectively than non-ciliated cells. Similar to prior observations in immortalized cell lines, we find that HA activation occurs intracellularly, constraining the antiviral activity of host-directed protease inhibitors. These results establish that HA activation within the airway epithelium depends on cellular tropism, and identify important considerations for the development of protease inhibitors as antivirals. ImportanceInfluenza entry requires the proteolytic activation of the viral fusion protein, hemagglutinin (HA). Activation occurs as new viruses are produced by infected cells. Efficient proteolytic activation is critical for viral pathogenesis, and inhibiting the requisite proteases could provide an effective host-directed antiviral strategy. To understand cellular constraints on HA activation and its sensitivity to inhibitors, we use complementary approaches to investigate these processes in differentiated airway epithelial cells. We find that ciliated cells activate HA with higher efficiency than non-ciliated cell types, establishing a new mechanism through which cellular tropism and virus infectious potential are connected. We also establish that HA activation begins in the Golgi, which may contribute to the limited the efficacy of inhibitors we observe despite their high in vitro potency.

microbiology↗

bioRxiv2025

Microengineered transplantation of human solid tumors for in vitro studies of CAR T immunotherapy

Treatment of solid malignancies using chimeric antigen receptor (CAR) T cells remains a significant challenge, but current efforts to advance this therapy are challenged by our limited capacity to probe and understand cancer-immune interactions in human solid tumors. Here, we present a microengineered platform for in vitro modeling of malignant solid tumors during CAR T therapy. This system makes it possible to vascularize human tumor explants and perfuse them with blood-borne immune cells in a controlled manner. We first present a microphysiological model of human lung adenocarcinomas infused with CAR-T cells and show how this system can be used to simulate, visualize, and interrogate tumor-directed trafficking and effector function of CAR T cells. We then demonstrate the proof-of-principle of testing a chemokine-directed CAR T cell engineering strategy in a model of malignant pleural mesothelioma and validating our in vitro assessment using a matching in vivo mouse model. Finally, we describe a potential therapeutic target discovered by single-cell RNA sequencing that can be pharmacologically modulated to increase the efficacy of CAR T cells for lung adenocarcinoma, for which we also present specific biomarkers identified by global metabolomics analysis. We believe that the bioengineering principle demonstrated here will make important contributions to developing new capabilities for preclinical studies of adoptive cell therapies for cancer and other complex diseases.

bioengineering↗

bioRxiv2025

Psmd13, a proteosome regulatory subunit identified in miR-29a regulation during neurogenesis

miR-29a is essential for neuronal development and implicated in neurodegenerative diseases, yet its regulatory mechanisms remain poorly understood. To identify upstream regulators of miR-29a expression, we leveraged the genetically diverse Collaborative Cross (CC) mouse strains and performed expression profiling and Quantitative Trait Loci (QTL) analysis, identifying a significant QTL on chromosome 7. Among ten candidate genes, Psmd13 emerged as a key regulator, with RNAi-mediated knockdown in mouse neural precursor cells (mNPCs) leading to enhanced neuronal differentiation and increased miR-29a expression in the undifferentiated state but decreased expression upon differentiation. Co-immunoprecipitation assays revealed that Psmd13 interacts with Dicer, modulating miR-29a levels in a differentiation-dependent manner. Chromatin immunoprecipitation sequencing (ChIP-seq) demonstrated Psmd13-Dicer co-binding at genomic loci, including miR-29a, suggesting a role in chromatin accessibility and transcriptional regulation. Proteasome inhibition using MG132 reduced Psmd13 and Dicer levels, downregulating miR-29a and impairing neuronal differentiation. These findings indicate that differentiation dynamically alters miR-29a transcription through Psmd13-Dicer interactions, positioning Psmd13 as a critical mediator of miR regulation and neurodevelopmental homeostasis.

developmental biology↗

bioRxiv2025

Au18(L-NIBC)14 targets ASC oligomerization for autoimmune disease treatment

Gold nanoclusters (AuNCs), unlike conventional nanoparticles, possess molecular characteristics besides ultrasmall nano-features. Recently, we and others showed that AuNCs are promising in treatments of various major diseases. However, the AuNCs used were usually mixtures, and the specific target and their relationship with AuNC structures are unclear, which largely restrict their druggability. Multiple sclerosis (MS) is an autoimmune disease (AID) implicating central nervous system (CNS), in which drug discovery is challenging. Here we used Au18(L-N-isobutyryl-L-cysteine)14 (Au18(L-NIBC)14) and Au25(L-NIBC)18, two AuNCs with the same ligand, to report their much different therapeutic effects in experimental autoimmune encephalomyelitis (EAE). We show that, Au18(L-NIBC)14, but not Au25(L-NIBC)18, specifically targets apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization, thus inhibit the activation of ASC-dependent inflammasomes, resulting in comprehensive restoration of cytokine homeostasis in the CNS of EAE mice. Au18(L-NIBC)14 significantly prevents axon demyelination, protects blood-brain barrier, blocks immune cell infiltration into CNS, and completely prevents motor deficits and relieve the early-cognitive impairments of EAE mice. Remarkable efficacies were also observed in animal models of inflammatory bowel disease, psoriasis, systemic lupus erythematosus, indicating a broad prospect in AIDs treatments. Especially, definite molecular structure, specific target, clear mechanism, and exact therapeutic effects imply a good druggability of Au18(L-NIBC)14.

pharmacology and toxicology↗

bioRxiv2025

Lamin A/C safeguards replication initiation by orchestrating chromatin accessibility and PCNA recruitment

Lamin A/C, a nuclear lamina protein, is essential for maintaining nuclear architecture, organizing chromatin and preserving genomic stability. However, its role in regulating DNA replication remains unclear. This study investigates how Lamin A/C regulates proper activation of replication origins by orchestrating the chromatin structure and recruitment of proliferating cell nuclear antigen (PCNA). We demonstrate that Lamin A/C stabilizes replication domains (RDs) by restricting chromatin mobility, preserving spatial organization, and maintaining accessibility. Furthermore, Lamin A/C interacts with PCNA and sequesters a pool of PCNA, to regulate its recruitment to replication machinery. The loss of Lamin A/C leads to an increase in chromatin dynamics, RD accessibility, and PCNA availability at RDs, which together trigger excessive activation of replication origins, leading to replication stress and DNA damage. These disruptions prolong the S phase and compromise genome stability, highlighting Lamin A/C as a critical gatekeeper of balanced replication initiation. Our findings reveal Lamin A/Cs dual role in chromatin organization and replication machinery regulation, offering valuable insights into its involvement in replication-associated diseases and potential therapeutic opportunities through targeting replication dynamics.

biophysics↗

bioRxiv2025

Impact of the rotational speed and counter electrode configuration on the performance of a rotating disc bioelectrochemical reactor (RDBER) operated as microbial electrolysis cell

A 10 L Rotating Disc Bioelectrochemical Reactor (RDBER) was operated as a microbial electrolysis cell (MEC) under different rotational speeds and counter electrode configurations. Increasing the anodes speed from 0.25 to 1 rpm raised the anodic current density from 55 {+/-} 14 to 100 {+/-} 7 A m-3 while increasing hydrogen production rates from 0.05 {+/-} 0.01 to 0.18 {+/-} 0.01 [Formula]. Higher speeds provided no further benefit. Moving the counter electrodes to the upper reactor half reduced observed hydrogen shuttling. The modified RDBER reached current densities of 1.98 {+/-} 0.11 A m-2 and 0.99 {+/-} 0.03 [Formula] hydrogen production. Optical coherence tomography confirmed biofilm morphology changes but no significant increase in biovolume or substratum coverage. Hydrogen recovery remained below 50%. While the RDBER achieved high volumetric current densities and volumetric hydrogen production rates compared to other MEC pilots, improvements in anodic current density and cathodic hydrogen recovery are required for practical application. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=87 SRC="FIGDIR/small/641858v1_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@f8e054org.highwire.dtl.DTLVardef@14fbaaeorg.highwire.dtl.DTLVardef@1692978org.highwire.dtl.DTLVardef@121b116_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LI10 L RDBER was operated as MEC in batch experiments at different rotational speeds C_LIO_LIhydrogen shuttling was reduced through cathode displacement C_LIO_LICurrent densities of 198 {+/-} 11 A m-3 and H2-production rates of 0.99 {+/-} 0.03 L LR-1 d-1 C_LIO_LIAnodic biofilm parameters were not significantly altered by cathode modification C_LI

bioengineering↗

bioRxiv2025

Targeting CD38 effectively prevents myelofibrosis in myeloproliferative neoplasms

Proinflammatory signaling is a hallmark of myeloproliferative neoplasms (MPNs). Several studies have shown that monocytes are a major source of proinflammatory cytokines and monocyte-derived fibrocytes play a pivotal role in the pathogenesis of myelofibrosis (MF). To further explore the role of monocytes in MF, we generated inducible NrasG12D/+Jak2V617F/+(NJ) mice. Recipients transplanted with NJ bone marrow cells developed MF with an early onset of anemia and monocytosis. In vitro, NJ recipients bone marrow nucleated cells exhibited increased quantity of CD45+CollagenI+ fibrocytes, which were mainly derived from the Ly6chigh monocytes. RNA sequencing identified a significant elevated expression of CD38 (a nicotinamide adenine dinucleotide (NAD)+ hydrolase) in Ly6chigh monocytes from NJ mice, which results in pronounced lower level of NAD+. In humans, CD14+ monocytes from MF patients showed significantly higher expression of CD38 than controls and monocytes from polycythemia vera (PV) patients with grade 1 fibrosis had higher CD38 expression than those without fibrosis. Finally, we tested that boosting NAD+ via pharmacological CD38 targeting or NAD+ precursor supplementation inhibited the differentiation of fibrocytes in vitro and observed that targeting CD38 can effectively prevent the onset of fibrosis in vivo. Collectively, our findings shed light on the role of CD38 in monocytes and suggest potential clinical applications such as use of CD38 as a biomarker of fibrotic progression and potential clinical utility of CD38 inhibition in patients with MF. Key PointsO_LICD38-overexpressing monocytes are increased in MF murine models and MPN patients progressing to fibrotic-phase disease. C_LIO_LIRestoring intracellular NAD+ levels using the CD38 inhibitor 78c prevented the development of fibrotic-phase disease in MPN murine models. C_LI

cancer biology↗

bioRxiv2025

Identification of actionable targeted protein degradation effector sites through Site-specific Ligand Incorporation-induced Proximity (SLIP)

Targeted protein degradation (TPD) is a rapidly emerging and potentially transformative therapeutic modality. However, the large majority of >600 known ubiquitin ligases have yet to be exploited as TPD effectors by proteolysis-targeting chimeras (PROTACs) or molecular glue degraders (MGDs). We report here a chemical-genetic platform, Site-specific Ligand Incorporation-induced Proximity (SLIP), to identify actionable ("PROTACable") sites on any potential effector protein in intact cells. SLIP uses genetic code expansion (GCE) to encode copper-free "click" ligation at a specific effector site in intact cells, enabling in situ formation of a covalent PROTAC-effector conjugate against a target protein of interest (POI). Modification at actionable effector sites drives degradation of the targeted protein, establishing the potential of these sites for TPD. Using SLIP, we systematically screened dozens of sites across E3 ligases and E2 enzymes from diverse classes, identifying multiple novel potentially PROTACable effector sites which are competent for TPD. SLIP adds a powerful approach to the proximity-induced pharmacology (PIP) toolbox, enabling future effector ligand discovery to fully enable TPD, and other emerging PIP modalities.

molecular biology↗

bioRxiv2025

Endothelial Cu Uptake Transporter CTR1 Senses Disturbed Flow to Promote Atherosclerosis through Cuproptosis

Endothelial cells (ECs) lining blood vessels sense disturbed blood flow (D-flow), which drives mitochondrial dysfunction and atherosclerosis. Copper (Cu) is an essential micronutrient, and its disruption of homeostasis has been implicated in atherosclerosis. Cellular Cu levels are tightly controlled by Cu transport proteins including the Cu importer CTR1. Cuproptosis is a recently discovered form of regulated cell death triggered by mitochondrial Cu accumulation, but its endogenous stimulants and role in atherosclerosis remain unknown. Using EC-specific CTR1-deficient mice and cultured ECs, we show that endothelial CTR1 responds to D-flow by increasing mitochondrial Cu levels through its interaction with the mitochondrial Cu transporter SLC25A3 at caveolae/lipid rafts. This leads to the aggregation of lipoylated mitochondrial proteins, mitochondrial dysfunction, and cuproptosis, thereby exacerbating atherosclerosis. Importantly, mitochondria-targeted Cu-chelating nanoparticles effectively mitigate D-flow-induced cuproptosis and atherosclerosis, highlighting the endothelial CTR1-SLC25A3-mitochondrial Cu axis as a potential therapeutic target.

cell biology↗

bioRxiv2025

Avoidance of fratricide and improved efficacy of CD33-MSLN CAR-iNK cells in treating acute myeloid leukemia

Acute myeloid leukemia (AML) patients are often older, which brings challenges of endurance and persistent efficacy of autologous CAR-T cell therapies. Allogenic CAR-NK cell therapies may offer reduced toxicities and enhanced anti-leukemic potential against AML. In this study, we designed a novel CD33-mesothelin loop CAR (Loop CAR) and evaluated its anti-tumor efficacy in human umbilical cord blood-derived NK (UCB-NK) cells and human pluripotent stem cell-derived NK (hPSC-iNK) cells. The Loop CAR exhibited superior cytotoxicity against dual-antigen-positive tumor cell lines and primary AML cells. To further avoid fratricide caused by endogenous CD33 expression in NK cells, we established a hPSC-derived cell line via knockout of CD33 gene (CD33KO) and engineered Loop CAR. Rather than enforced expression of exogenous CD16, we generated abundant mature CD33KO-Loop CAR-iNK cells highly expressing endogenous CD16 via an organoid induction approach. This innovative strategy effectively mitigated NK cell fratricide and significantly enhanced CD33 and mesothelin-mediated specific cytotoxicity. Moreover, the CD33KO-Loop CAR-iNK cells demonstrated superior tumor-killing activity in AML xenograft mice and significantly prolonged survival. hPSC-derived CD33KO-Loop CAR-iNK cells possess unique advantages and translational potential for treating AML.

cancer biology↗

bioRxiv2025

Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies

BackgroundT cell malignancies are highly aggressive hematological tumors with limited effective treatment options. CAR-NK cell therapy targeting CD7 has emerged as a promising approach for treating T-cell malignancies. However, conventional CAR-NK cell therapy faces the challenges of cell fratricide due to CD7 expression on both malignant cells and normal NK cells. Additionally, engineering CARs into human tissue-derived NK cells demonstrates heterogeneity, low transduction efficiency, and high manufacturing costs. MethodsThe human pluripotent stem cells (hPSCs) were genetically modified by knocking out the CD7 gene and introducing the CD7 CAR expression cassette to generate CD7 KO-CD7 CAR-hPSCs. These modified hPSCs were subsequently differentiated into CD7 KO-CD7 CAR-iNK cells using an efficient organoid induction method. The cytotoxicity of CD7 KO-CD7 CAR-iNK cells against CD7+ tumor cells was evaluated. Furthermore, we overexpressed the CXCR4 gene in CD7 KO-CD7 CAR-hPSCs and derived CXCR4-expressing CD7 KO-CD7 CAR-iNK (CRO-CD7 CAR-iNK) cells. The dynamics of CRO-CD7 CAR-iNK cells in vivo were tracked, and their therapeutic efficacy was assessed using human T-cell acute lymphoblastic leukemia (T-ALL) xenograft models. ResultsThe CD7 KO-CD7 CAR-iNK cells derived from CD7 KO-CD7 CAR-hPSCs effectively avoided fratricide, demonstrated normal expansion, and exhibited potent and specific anti-tumor activity against CD7+ T-cell tumor cell lines and primary T-ALL cells. CXCR4 overexpression in CRO-CD7 CAR-iNK cells improved their homing capacity and extended their persistence in vivo. The CRO-CD7 CAR iNK cells significantly suppressed tumor growth and prolonged the survival of T-ALL tumor-bearing mice. ConclusionsOur study provides a reliable strategy for the large-scale generation of fratricide-resistant CD7 CAR-iNK cells with robust anti-tumor effects from hPSCs, offering a promising cell product to treat T-cell malignancy.

cancer biology↗